It was reported that the battery of this implantable pacemaker device was suspected to be depleting prematurely.This device was implanted for approximately a year now and the battery shows five years remaining.Boston scientific technical services (ts) noted that there was a slight increase in power consumption and the patient was in chronic atrial fibrillation (af).Ts also discussed the impact of high-rate atrial sensing on battery longevity, and that device is of standard longevity.Device reprogramming was recommended, and the patient will continue to be monitored.This device remains in service.No adverse patient effects were reported.
|